Coccaro, Emil F.
Lee, Royce
Breen, Elizabeth C.
Irwin, Michael R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (RO1 MH104673)
Article History
Received: 15 September 2022
Revised: 5 January 2023
Accepted: 24 January 2023
First Online: 17 February 2023
Competing interests
: EFC reports being a consultant to and being on the Scientific Advisory Boards of Azevan Pharmaceuticals, Inc., Avanir Pharmaceuticals, Inc., Boerhinger Ingelheim, Pharma, Inc., and being a current recipient of a grant award from the NIMH and NIAAA. RL, ECB, and MRI report no biomedical financial interests or competing interests.